The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2025

Filed:

Nov. 16, 2016
Applicant:

Kinomica Limited, Macclesfield, GB;

Inventors:

Pedro Rodriguez Cutillas, London, GB;

Edmund Wilkes, London, GB;

Pedro Casado-Izquierdo, London, GB;

Assignee:

KINOMICA LIMITED, Macclesfield, GB;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); G16B 20/20 (2019.01); G16B 40/10 (2019.01); G16H 20/00 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6848 (2013.01); G16B 20/20 (2019.02); G16B 40/10 (2019.02); G16H 20/00 (2018.01); G01N 2440/00 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides a method of quantifying the activity of a protein modifying enzyme in a sample, comprising calculating the value K for said protein-modifying enzyme on the basis of the number of modified peptides in a sample that are substrates of said protein modifying enzyme, the intensity of the modified peptides, each modified peptide in the sample that is a substrate of said protein modifying enzyme, the total number of modified peptides in the sample, the intensity of the modified peptides and all of the modified peptides in the sample. A method of quantifying the activity of a protein modifying enzyme in a sample, comprising calculating the value SC for said protein-modifying enzyme on the basis of a reduction in proliferation using an inhibitor at an inhibitor concentration at which proliferation is measured and the 'in vitro' IC50i of the inhibitor against a primary target is also provided. The invention further provides methods of identifying inhibitors with which to treat a patient, methods of treatment, a computer readable medium, a computer program product and devices for carrying out the methods.


Find Patent Forward Citations

Loading…